• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Tuesday, May 30, 2023
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Novel technology could prevent repeat operations to replace a faulty bioprosthetic heart valve

Bioengineer by Bioengineer
March 1, 2022
in Science News
Reading Time: 4 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

 

Heart Illustration

Credit: Tel Aviv University

 

  • Many patients implanted with a bioprosthetic heart valve are forced to undergo complicated valve replacement surgery ten years later due to valve calcification.
  • Novel technology offers more durable valves based on genetic engineering preventing expression of foreign sugars, thereby minimizing structural valve deterioration due to calcification.

 

An international study led by a researcher from Tel Aviv University offers a novel technology that can assist many patients implanted with bioprosthetic heart valve by avoiding additional complicated replacement surgery. Many heart patients implanted with such valves are forced to replace it ten years later due to calcification of valve tissue. The researchers have now been able to show that by genetically engineering the biological component in the valve – it was possible to avoid immunological attack and calcification risk, thereby offering next-generation durable bioprosthetic heart valves. The study was published in the prestigious journal Nature Medicine.

This technological development stems from the EU-funded TRANSLINK consortium consisting of 14 members from Europe, USA and Canada and led by Dr. Vered Padler-Karavani from The Shmunis School of Biomedicine and Cancer Research at Tel Aviv University. In this study the researchers investigated close to 1700 patients with ~5000 blood samples covering almost 15 years since implantation.

The researchers explain that patients can be implanted with either a mechanical heart valve that last long but requires daily administration of anticoagulants that can lead to life-threatening hemorrhages, or bioprosthetic heart valves (made from bovine, porcine or equine tissue) allowing patients to live a reasonably normal life, but those are commonly destroyed after a decade requiring replacement.

Dr. Padler-Karavani: “since bioprosthetic heart valves are made of animal tissues, we hypothesized they contain foreign non-human sugars (Neu5Gc and alpha-Gal) that are attacked by the human immune system, which then mediate the calcification that lead to structural valve deterioration. Indeed, in our research we proved that this was the reason and even suggested an implementable solution.

We discovered that all bioprosthetic heart valve patients developed an immune response against the foreign sugars in the valves. We could clearly see an increase in antibody responses against these sugars in implanted patients, as early as one month after implantation, some lasting even two years later. We also found that some of the patients showed signs of calcification as early as two years post implantation”.

Anu Paul, a postdoc in the lab, also showed that the foreign sugars and the antibodies attacking them were found on calcified bioprosthetic heart valves explanted from patients some 10 years after implantation. Additionally, the dietary non-human sugar Neu5Gc and the antibodies against it were also found on explanted calcified native valves (the original malfunctioning human valves that needed to be replaced with a bioprosthesis). Since this sugar cannot be produced in the human body, it most likely accumulates on these valves from diet rich in red meat and dairy products where it is abundant. Therefore, it is possible that red meat diet mediates the initial need for valve replacement. The researchers also confirmed in a human-like animal model that antibodies against the foreign sugars indeed mediate calcification of tissues used for production of bioprosthetic heart valves.

Furthermore, the option to employ genetic engineering to resolve the problem was examined. For this purpose, the consortium created genetically modified porcine (pigs) that do not express the sugars foreign to humans. In Dr. Padler-Karavani’s lab the researchers found that in a human-like animal model that engineered tissue lacking the foreign sugars significantly had reduced calcification even in the presence of antibodies against the sugars and can therefore increase the durability of bioprosthetic heart valves made of such tissues.

“This study marks breakthrough technology in the field of bioprosthetic heart valves and provides deep understanding of the mechanisms leading to structural valve deterioration. These findings can lead to a dramatic improvement in the quality of life of many heart patients. Now it would be interesting to study whether vegetarians or people who consume only small amounts of red meat and dairy have lower probability of heart valve calcification, and if this could perhaps be associated with low levels of antibodies against these foreign sugars. In the future it may also be possible to devise a modified diet to reduce the risk or to actually produce biological valves from the tissues of engineered animals that do not contain the sugars at all”, Dr. Padler-Karavani summarizes.

TRANSLINK consortium management team included also Rafael Mañez, Jean-Christian Roussel, Jean-Paul Soulillou and Emanuele Cozzi (the coordinator). Thomas Senage and Thierry Le Tourneau from France led investigation of the clinical arm of the study. At Dr. Padler-Karavani’s lab the study was led by Anu Paul (currently a postdoc at Harvard University) along with Salam Bashir and with the assistance of other researchers and students.

Link to the article:

https://www.nature.com/articles/s41591-022-01682-w



Journal

Nature Medicine

DOI

10.1038/s41591-022-01682

Article Title

The role of antibody responses against glycans in bioprosthetic heart valve calcification and deterioration

Article Publication Date

17-Feb-2022

Share12Tweet8Share2ShareShareShare2

Related Posts

Obstructive sleep apnea disrupts gene activity throughout the day in mice

Obstructive sleep apnea disrupts gene activity throughout the day in mice

May 30, 2023
michael HIV vaccine

Researchers use ‘natural’ system to identify proteins most useful for developing an effective HIV vaccine

May 30, 2023

Scientists identify how some angiogenic drugs used to treat cancer and heart disease cause vascular disease

May 30, 2023

CSI Singapore researchers uncover potential novel therapeutic targets against natural killer/T-cell lymphoma

May 30, 2023

POPULAR NEWS

  • plants

    Plants remove cancer causing toxins from air

    39 shares
    Share 16 Tweet 10
  • Element creation in the lab deepens understanding of surface explosions on neutron stars

    36 shares
    Share 14 Tweet 9
  • Groundbreaking study uncovers first evidence of long-term directionality in the origination of human mutation, fundamentally challenging Neo-Darwinism

    115 shares
    Share 46 Tweet 29
  • How life and geology worked together to forge Earth’s nutrient rich crust

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Obstructive sleep apnea disrupts gene activity throughout the day in mice

Researchers use ‘natural’ system to identify proteins most useful for developing an effective HIV vaccine

Scientists identify how some angiogenic drugs used to treat cancer and heart disease cause vascular disease

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 50 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In